Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Innovent Receives IND Approval of a Bispecific Antibody (IBI318) by the NMPA 2019-02-07 22:37
NanoRacks Senior Leaders Speak in Japan at JAXA International Space Station "Kibo" Utilization Symposium 2019-02-07 08:30
BioLineRx Announces Pricing of $15.4 Million Underwritten Public Offering of its American Depositary Shares and Warrants 2019-02-06 00:40
Primex Pharmaceuticals appoints Alan Knox as Group CEO 2019-02-06 00:14
Taiho Pharmaceutical and Cullinan Oncology Establish Collaboration to Develop TAS6417, Novel EGFR Tyrosine Kinase Inhibitor 2019-02-05 16:00
GeneQuantum Healthcare and MITRO Biotech Enter into Strategic Cooperation to Develop Next Generation Radionuclide Conjugates 2019-02-03 20:00
I-Mab Biopharma and Bio-Cancer Treatment International Announce Intention for Collaboration on Arginine Depletion Therapy and Biomarker Study, with Plans for I-Mab to Establish a Translational Medicine Lab in Hong Kong 2019-02-01 17:46
TOLSURA (TM) (SUBA®-itraconazole) Antifungal Capsule Now Available in the United States 2019-01-30 20:30
CARsgen Therapeutics Receives IND Clearance for GPC3-CAR-T Cells from the NMPA 2019-01-29 18:00
NMPA Accepts New Drug Application for IBI-305, a Biosimilar Product Candidate of Bevacizumab (Avastin®) 2019-01-29 12:19
CStone receives CTA approval in China to start Phase I trial for FGFR4 inhibitor BLU-554 (CS3008) 2019-01-29 10:19
I-Mab Receives IND Approval from the US FDA to Initiate Clinical Trials for Its Proprietary TJC4, a Potential Global Best-in-Class Anti-CD47 Monoclonal Antibody 2019-01-28 21:58
Gratomic and TODAQ announce supply chain partnership to track commercial graphene from source to end consumer on the TODA protocol 2019-01-26 05:34
Pfizer actively pushes forward the development and innovation of breast cancer treatment that enhances patients' confidence 2019-01-23 18:11
I-Mab Biopharma Receives U.S. FDA IND Clearance for Proprietary CD73 Antibody TJD5 2019-01-22 22:04
Mundipharma to Provide Access to Breakthrough Cold-Fighting Product for Adults and Children in the Middle East and Africa 2019-01-22 13:25
TaiwanJ Pharmaceuticals Announces Positive Results from Phase 2 Orphan Drug Designation Study of JKB-122 on Autoimmune Hepatitis (AIH) 2019-01-22 10:45
OliX Announces Clinical Candidate Nomination for the Treatment of Geographic Atrophy 2019-01-18 14:50
Innovent Announces First Patient Dosed in a Phase III Clinical Trial of Anti-PD-1 Antibody Tyvyt® (Sintilimab injection) as First-line Treatment for Patients with Advanced Gastric Cancer 2019-01-17 08:00
Luye Pharma Reaches Strategic Partnership with AstraZeneca, Strengthens Commitment to Cardiovascular Therapeutic Field 2019-01-16 19:08
1 335 336 337 338 339 410